Suzanna M Zick

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial
    Jessica Citronberg
    University of Michigan Medical Center, 24 Frank Lloyd Wright Drive, Lobby M, P O Box 385, Ann Arbor, MI 48105
    Cancer Prev Res (Phila) 6:271-81. 2013
  2. ncbi Acupressure for persistent cancer-related fatigue in breast cancer survivors (AcuCrft): a study protocol for a randomized controlled trial
    Suzanna Maria Zick
    Department Family Medicine, University of Michigan, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48105, USA
    BMC Complement Altern Med 12:132. 2012
  3. ncbi Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005
    Heather S Boon
    Leslie Dan Faculty of Pharmacy and Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
    BMC Womens Health 7:4. 2007
  4. ncbi Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells
    Jennifer Rhode
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Michigan, Ann Arbor, MI, USA
    BMC Complement Altern Med 7:44. 2007
  5. ncbi Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer
    Suzanna M Zick
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Cancer Prev Res (Phila) 4:1929-37. 2011
  6. ncbi Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting
    Suzanna M Zick
    Departments of Family Medicine, University of Michigan, Ann Arbor, MI, USA
    Support Care Cancer 17:563-72. 2009
  7. ncbi Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects
    Suzanna M Zick
    Deoartment of Family Medicine, University of Michigan Medical School, Ann Arbor, MI 48104, USA
    Cancer Epidemiol Biomarkers Prev 17:1930-6. 2008
  8. ncbi Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial
    Suzanna M Zick
    Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109 0708, USA
    Eur J Heart Fail 11:990-9. 2009
  9. ncbi The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure
    Suzanna M Zick
    Department of Family Medicine, University of Michigan, Ann Arbor, MI 48104, USA
    Eur J Heart Fail 10:587-93. 2008
  10. ncbi Trial of Essiac to ascertain its effect in women with breast cancer (TEA-BC)
    Suzanna M Zick
    Integrative Medicine, University of Michigan, Ann Arbor, MI 48104 1555, USA
    J Altern Complement Med 12:971-80. 2006

Collaborators

Detail Information

Publications17

  1. ncbi Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial
    Jessica Citronberg
    University of Michigan Medical Center, 24 Frank Lloyd Wright Drive, Lobby M, P O Box 385, Ann Arbor, MI 48105
    Cancer Prev Res (Phila) 6:271-81. 2013
    ..Cancer Prev Res; 6(4); 271-81. ©2012 AACR...
  2. ncbi Acupressure for persistent cancer-related fatigue in breast cancer survivors (AcuCrft): a study protocol for a randomized controlled trial
    Suzanna Maria Zick
    Department Family Medicine, University of Michigan, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48105, USA
    BMC Complement Altern Med 12:132. 2012
    ....
  3. ncbi Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005
    Heather S Boon
    Leslie Dan Faculty of Pharmacy and Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
    BMC Womens Health 7:4. 2007
    ..The purpose of this paper is to compare overall patterns of CAM use, as well as use of specific products and therapies at two different points in time (1998 vs 2005) by women diagnosed with breast cancer...
  4. ncbi Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells
    Jennifer Rhode
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Michigan, Ann Arbor, MI, USA
    BMC Complement Altern Med 7:44. 2007
    ..In the present study, we investigated the effect of ginger on tumor cell growth and modulation of angiogenic factors in ovarian cancer cells in vitro...
  5. ncbi Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer
    Suzanna M Zick
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Cancer Prev Res (Phila) 4:1929-37. 2011
    ..Ginger also seemed to be tolerable and safe. Further investigation in people at high risk for CRC seems warranted...
  6. ncbi Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting
    Suzanna M Zick
    Departments of Family Medicine, University of Michigan, Ann Arbor, MI, USA
    Support Care Cancer 17:563-72. 2009
    ..Ginger has also been studied for its efficacy for acute chemotherapy-induced nausea and vomiting (CINV). However, its efficacy for delayed CINV in a diverse oncology population is unknown...
  7. ncbi Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects
    Suzanna M Zick
    Deoartment of Family Medicine, University of Michigan Medical School, Ann Arbor, MI 48104, USA
    Cancer Epidemiol Biomarkers Prev 17:1930-6. 2008
    ..We conducted a clinical trial with 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol, examining the pharmacokinetics and tolerability of these analytes and their conjugate metabolites...
  8. ncbi Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial
    Suzanna M Zick
    Department of Family Medicine, University of Michigan, Ann Arbor, MI 48109 0708, USA
    Eur J Heart Fail 11:990-9. 2009
    ..Hawthorn's efficacy when added to contemporary evidence-based heart failure therapy is unknown. We aimed to determine whether hawthorn increases submaximal exercise capacity when added to standard medical therapy...
  9. ncbi The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure
    Suzanna M Zick
    Department of Family Medicine, University of Michigan, Ann Arbor, MI 48104, USA
    Eur J Heart Fail 10:587-93. 2008
    ..To examine whether hawthorn (Crataegus Special Extract WS 1442 {CSE}) inhibits progression in heart failure (HF) patients...
  10. ncbi Trial of Essiac to ascertain its effect in women with breast cancer (TEA-BC)
    Suzanna M Zick
    Integrative Medicine, University of Michigan, Ann Arbor, MI 48104 1555, USA
    J Altern Complement Med 12:971-80. 2006
    ..rubra]), has become one of the more popular herbal remedies for breast-cancer treatment, secondary prevention, improving quality of life, and controlling negative side-effects of conventional breast-cancer treatment...
  11. ncbi Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study
    Suzanna M Zick
    University of Michigan, Department of Family Medicine, 1018 Fuller Street, Ann Arbor, MI 48104 1213, USA
    BMC Complement Altern Med 11:78. 2011
    ..We examined the preliminary efficacy and safety of chamomile for improving subjective sleep and daytime symptoms in patients with chronic insomnia...
  12. ncbi The prevalence and pattern of complementary and alternative supplement use in individuals with chronic heart failure
    Suzanna M Zick
    Department of Family Medicine, Ann Arbor, MI 48104, USA
    J Card Fail 11:586-9. 2005
    ..CAM supplement use for weight loss may be underreported. Demographic and behavioral characteristics may not have identified people with CHF who were using CAM supplements...
  13. ncbi Unique aspects of herbal whole system research
    Suzanna M Zick
    Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA
    Explore (NY) 5:97-103. 2009
    ..It was our objective to explore various conceptual and methodological issues surrounding whole system herbal research...
  14. ncbi Examination of the association of diet and persistent cancer-related fatigue: a pilot study
    Suzanna M Zick
    Department of Family Medicine, University of Michigan Health System, Ann Arbor, MI, USA
    Oncol Nurs Forum 40:E41-9. 2013
    ..To examine associations between diet and persistent cancer-related fatigue (PCRF) in cancer survivors...
  15. ncbi Quercetin blocks airway epithelial cell chemokine expression
    Suparna Nanua
    University of Michigan, 1150 W. Medical Center Drive, Box 0688, Ann Arbor, MI 48109-0688, USA
    Am J Respir Cell Mol Biol 35:602-10. 2006
    ..Quercetin significantly reduced lung MCP-1 and methacholine responsiveness. We conclude that quercetin blocks airway cell chemokine expression via transcriptional and post-transcriptional pathways...
  16. ncbi Challenges in herbal research: a randomized clinical trial to assess blinding with ginger
    Suzanna M Zick
    University of Michigan, Department of Family Medicine, 715 East Huron Street, Suite 1W, Ann Arbor, MI 48104, USA
    Complement Ther Med 13:101-6. 2005
    ..To assess methods to blind study participants to encapsulated ginger (Zingiber officinale)...
  17. ncbi Bridging CAM practice and research: teaching CAM practitioners about research methodology
    Suzanna M Zick
    University of Michigan, Department of Family Medicine, CAM Research Center, USA
    Altern Ther Health Med 10:50-6. 2004
    ..We offer suggestions for developing training opportunities both at the local and national level that would increase the expertise of CAM providers in participating and seeking funded research...